CNMD 241018 75.00C (CNMD241018C75000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CNMD241018C75000

Watchlist

2.60
-1.09-29.54%

15min DelayClose Sep 26 15:59 ET

2.60High2.60Low

Intraday

5D
Daily

News

Conmed Announces Executive Departure and New Interim Controller
TipRanksSep 20 17:29 ET
Surgical Power Tools Research Report 2024: A $2.97 Billion Market With Stryker, Medtronic, DePuy Synthes, Zimmer Biomet, B. Braun, and CONMED Dominating - ResearchAndMarkets.com
BusinesswireSep 18 11:20 ET
Radiofrequency Ablation Device Market Global Forecast Report and Company Analysis 2024-2032 Featuring Boston Scientific, Abbott, AtriCure, Medtronic, Stryker, Smith & Nephew, Conmed and Hologic - ResearchAndMarkets.com
BusinesswireSep 13 11:49 ET
ConMed To Go Ex-Dividend On September 16th, 2024 With 0.2 USD Dividend Per Share
Moomoo NewsSep 12 21:00 ET
Carpal Tunnel Release Systems Market Forecast Report 2024-2030, Featuring Profiles of Arthrex, Conmed, Innomed, MicroAire Surgical Instruments, Resurgens Orthopaedics, S2S Surgical and Trice Medical
Yahoo FinanceSep 12 11:21 ET
Why Investors Shouldn't Be Surprised By CONMED Corporation's (NYSE:CNMD) P/E
Simply Wall StSep 12 06:38 ET

Comments

wooper

Feb 20 20:58

excellent

Share Your Profit/Loss

Moomoo AI

Dec 18, 2023 20:02

CONMED's ROE is deemed 'sub-optimal'. The business isn't thrilling as it uses high debt to boost sub-par returns. Theoretically, greater ROE could improve through leverage, but higher debt presents greater risk.

With A 7.3% Return On Equity, Is CONMED Corporation (NYSE:CNMD) A Quality Stock?

Moomoo AI

Nov 3, 2023 22:38

CONMED's stock appears overpriced when gauged against the industry average PE ratio. Despite its positive outlook being factored into its valuation, the elevated price could present a risk to potential sellers and isn't the optimum entry point for potential investors.

Is It Time To Consider Buying CONMED Corporation (NYSE:CNMD)?

Moomoo AI

Oct 13, 2023 21:28

CONMED's move to profitability is typically seen as a good sign but investor sentiment may be changing due to recent share price drop. The company exhibits two cautionary signs for investors.

CONMED's (NYSE:CNMD) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth

Moomoo Breakfast US

Jun 1, 2022 20:21

Columns Today's pre-market stock movers: CRM, WB, LI, NIO and more

Gainers:
• $Victoria's Secret (VSCO.US)$ +10.4% (In reaction to earnings)
• $Salesforce (CRM.US)$ +9.0% (In reaction to earnings)
• $Navigator (NVGS.US)$ +4.9% (names Mads Peter Zacho as CEO)
• $Weibo (WB.US)$ +4.7% (In reaction to earnings)
• $CAE Inc (CAE.US)$ +4.7% (In reaction to earnings)
• $Laredo Petroleum (LPI.US)$ +4% (authorized $200 mln share repurchase program)
• $Axsome Therapeutics (AXSM.US)$ +3.1% (Late-Breaking Presentations of P...